( A ) Western blot analysis of sAC in bound and unbound fractions from pull-down experiments using streptavidin magnetic beads with biotinylated GLP-1(2836) and scrambled control incubated with mouse whole-heart lysates indicated no sAC binding to either peptide
Dankner R, Boker LK, Boffetta P et al (2018) A historical cohort study on glycemic-control and cancer-risk among patients with diabetes
Key takeaway: Nausea is the most common side effect when starting GLP-1 medications, but it is typically temporary and manageable
Although a large number of short-term and medium-term clinical studies support the safety and efficacy of GLP-1RAs, there are insufficient data on the presence of delayed side effects with their long-term (decades) use (Guirguis et al., 2024)
Clinical trials investigating the effects of different GLP-1RAs on myosteatosis through magnetic resonance imaging (MRI) subgroup analyses in mostly middle-aged adults (mean ages 50 to 56 years) have generally reported promising findings
A European health authority, however, announced that it couldnt find any link in humans
